IGF2BP2 and polycystic ovary syndrome: IMP2 is implicated in polycystic ovarian syndrome (PCOS), a condition typified by infertility, inflammation, irregular menstrual cycles, multiple ovarian cysts, and an increased risk of progression to ovarian cancer [37].